Audits or reviews Sample Clauses

Audits or reviews.  The results of any audits or reviews of Ore Reserve estimates.  No audits carried out.
Sample 1
AutoNDA by SimpleDocs
Audits or reviews. In addition to the independent audit contemplated by Section 4(i), below, upon not less than 10 days’ notice from the AF-CH-HH Group to the Management Company, and at the sole cost and expense of the AF-CH-HH Group, the Management Company shall cooperate and furnish the AF-CH-HH Group or its designees with any and all information necessary to perform and complete any and all audits or review procedures deemed necessary by the AF-CH-HH Group, in the AF-CH-HH Group’s reasonable discretion, to determine the accuracy and correctness of the accounting and internal controls performed and maintained by the Management Company; provided, however that any such designee of the AF-CH-HH Group shall not be a direct or substantial competitor of the Management Company or any member of the AF-CH-HH Group. Any such audit or review shall be conducted at such time and in such manner so as to avoid undue disruption of the Management Company’s business operations.
Sample 1
Audits or reviews. Review work undertaken in relation to the mineral resource estimate has included visual review of cross-sections comparing blocks to down hole grades. Populations of grades, composites and blocks and their general distribution have been reviewed to ensure no bias in estimation. In addition, confirmatory drilling has been conducted which reasonably supports the predictions made by the block model. Third party auditors have also inspected the cross-sections and mineral resource findings without issue. Discussion of relative • Accuracy and variability have been assessed through visual review of cross-sections, accuracy/confidence comparing blocks to drill hole grades. • This mineral resource estimation has reasonable global reliability but local variability is subject to the nugget effect observed in variography. It is the Competent Person’s opinion that indicated and inferred mineral resources are of sufficient reliability to support scoping level economic analysis and make preliminary mining plans. • No production data are available. In Solid Kriging Error Search Radius Min Points Anisotropy Primary: Tertiary High Park Deposit Measured Yes <1.3 160 4 3:1 Indicated Yes <1.3 320 8 3:1 Inferred A Yes >1.3 500 8 3:1 Xxxxxx and Picnic Tree Deposit Indicated Yes <2.1 300 4 16:1 Inferred A Yes >2.1 500 4 16:1 Xxxxxx Ranch and Xxxxx Deposit Indicated Yes <1.3 320 8 3:1 Inferred A Yes >1.3 500 8 3:1 Competent Person’s Consent Form Pursuant to the requirements of ASX Listing Rules 5.6, 5.22 and 5.24 and Clause 9 of the JORC Code 2012 Edition (Written Consent Statement)
Sample 1
Audits or reviews.  The results of any audits or reviews of sampling techniques and data. None completed. JORC Code, 2012 Edition – Table 1 Section 2 Reporting of Exploration Results Criteria JORC Code explanation Commentary Mineral tenement and land tenure status  Type, reference name/number, location and ownership including agreements or material issues with third parties such as joint ventures, partnerships, overriding royalties, native title interests, historical sites, wilderness or national park and environmental settings.  The security of the tenure held at the time of reporting along with any known impediments to obtaining a licence to operate in the area. Private surface and mineral ownership exist at Xxxxxx Ridge. Metals of Americas, LLC has entered into mineral leases over the surface and mineral rights to the Xxxxxx Ridge Zinc Project. The Company has entered into a Binding Exclusivity Agreement to potentially to acquire 100% of issued capital in Metals of Americas, LLC. There are no known material issues affecting the mineral leases. All tenements have been legally validated by a land manager to confirm title to the relevant surface and mineral rights. Exploration done by other parties  Acknowledgment and appraisal of exploration by other parties. Cominco American Resources Incorporated initially conducted exploration at Xxxxxx Ridge. Cominco discovered the prospect in 1983 during a grass-roots exploration program. They drilled 8 holes on the property, but terminated their lease agreements by the end of 1986. 6 of those drill holes were collared within 250m of the summit of Xxxxxx Xxxx, on the downdip extent of the gossan. Between 1994-1996, Xxxxxx Dodge drilled an additional 13 holes in the Xxxxxx Ridge vicinity. This work was followed by exploration and minimal drilling conducted by Xxxxxx Ridge, LLC (2 holes) and MMG (2 holes) between 2013-2016. While only limited exploration has been conducted at Xxxxxx Ridge, significant Pb, Zn, and Ag intercepts have resulted. Furthermore, significant mineralized drill intercepts confirm the sedex model at Xxxxxx Ridge. Geology  Deposit type, geological setting and style of mineralisation. The Xxxxxx Ridge prospect shows similarities to the Xxxxxxxx Deposit (> 160 Mt of ore grading 12% combined Pb and Zn, and +2 ounce Ag), in its tectonic and time- stratigraphic settings. The Xxxxxxxx deposit in British Columbia is hosted by Proterozoic clastic sediments of the Xxxxxxxx/Xxxxxxxx Formation, the basal portion of the Bel...
Sample 1
Audits or reviews. The results of any audits or reviews of sampling techniques and data. No independent audit or review has been undertaken.
Sample 1
Audits or reviews. The results of any audits or reviews of sampling techniques and data. • Not Applicable
Sample 1
Audits or reviews. The results of any audits or reviews of sampling techniques and data. • The recent drilling has not been independently reviewed except by Mining One who are responsible for the resource estimation process.
Sample 1
AutoNDA by SimpleDocs

Related to Audits or reviews

  • Reviews (a) During the term of this Agreement and for 7 years after the term of this Agreement, the HSP agrees that the LHIN or its authorized representatives may conduct a Review of the HSP to confirm the HSP’s fulfillment of its obligations under this Agreement. For these purposes the LHIN or its authorized representatives may, upon 24 hours’ Notice to the HSP and during normal business hours enter the HSP’s premises to:

  • Periodic Reviews During January of each year during the term hereof, the Board of Directors of the Company shall review Executive's Annual Salary, bonus, stock options, and additional benefits then being provided to Executive. Following each such review, the Company may in its discretion increase the Annual Salary, bonus, stock options, and benefits; however, the Company shall not decrease such items during the period Executive serves as an employee of the Company. Prior to November 30th of each year during the term hereof, the Board of Directors of the Company shall communicate in writing the results of such review to Executive.

  • Performance Reviews The Employee will be provided with a written performance appraisal at least once per year and said appraisal will be reviewed at which time all aspects of the assessment can be fully discussed.

  • Audits No more than once a year, or following unauthorized access, upon receipt of a written request from the LEA with at least ten (10) business days’ notice and upon the execution of an appropriate confidentiality agreement, the Provider will allow the LEA to audit the security and privacy measures that are in place to ensure protection of Student Data or any portion thereof as it pertains to the delivery of services to the LEA . The Provider will cooperate reasonably with the LEA and any local, state, or federal agency with oversight authority or jurisdiction in connection with any audit or investigation of the Provider and/or delivery of Services to students and/or LEA, and shall provide reasonable access to the Provider’s facilities, staff, agents and XXX’s Student Data and all records pertaining to the Provider, LEA and delivery of Services to the LEA. Failure to reasonably cooperate shall be deemed a material breach of the DPA.

  • Audit Notwithstanding any other audit requirement, H-GAC reserves the right to conduct or cause to be conducted an independent audit of any transaction under this Agreement, such audit may be performed by the H-GAC local government audit staff, a certified public accountant firm, or other auditors designated by H-GAC and will be conducted in accordance with applicable professional standards and practices. The Contractor understands and agrees that the Contractor shall be liable to the H-GAC for any findings that result in monetary obligations to H-GAC.

  • Review The practitioner reviews the treatment plan and discusses, when appropriate, case circumstances and management options with the attending (or referring) physician. The reviewer consults with the requesting physician when more clarity is needed to make an informed coverage decision. The reviewer may consult with board certified physicians from appropriate specialty areas to assist in making determinations of coverage and/or appropriateness. All such consultations will be documented in the review text. If the reviewer determines that the admission, continued stay or service requested is not a covered service, a notice of non-coverage is issued. Only a physician, behavioral health practitioner (such as a psychiatrist, doctoral-level clinical psychologist, certified addiction medicine specialist), dentist or pharmacist who has the clinical expertise appropriate to the request under review with an unrestricted license may deny coverage based on medical necessity.

  • Recommendations It is recommended that:

  • Investigations The respective representations and warranties of the Parties contained in this Agreement or any certificate or other document delivered by any Party at or prior to the Closing and the rights to indemnification set forth in Article XI shall not be deemed waived or otherwise affected by any investigation made, or knowledge acquired, by a Party.

  • Due Diligence Review; Information The Company shall make available, during normal business hours, for inspection and review by the Investors, advisors to and representatives of the Investors (who may or may not be affiliated with the Investors and who are reasonably acceptable to the Company), all financial and other records, all SEC Filings (as defined in the Purchase Agreement) and other filings with the SEC, and all other corporate documents and properties of the Company as may be reasonably necessary for the purpose of such review, and cause the Company’s officers, directors and employees, within a reasonable time period, to supply all such information reasonably requested by the Investors or any such representative, advisor or underwriter in connection with such Registration Statement (including, without limitation, in response to all questions and other inquiries reasonably made or submitted by any of them), prior to and from time to time after the filing and effectiveness of the Registration Statement for the sole purpose of enabling the Investors and such representatives, advisors and underwriters and their respective accountants and attorneys to conduct initial and ongoing due diligence with respect to the Company and the accuracy of such Registration Statement. The Company shall not disclose material nonpublic information to the Investors, or to advisors to or representatives of the Investors, unless prior to disclosure of such information the Company identifies such information as being material nonpublic information and provides the Investors, such advisors and representatives with the opportunity to accept or refuse to accept such material nonpublic information for review and any Investor wishing to obtain such information enters into an appropriate confidentiality agreement with the Company with respect thereto.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

Time is Money Join Law Insider Premium to draft better contracts faster.